Abstract
Stroke assessment is critical, complex, and should include integrative techniques combining clinical/functional, neurostructural, and biochemical markers. Accurate assessment of stroke and its appropriate timely management are essential to ensure a favorable outcome avoiding the risk of recurrent events. There is still an unmet medical need in search of key indicators that will be associated with the complexity of structural/sub-structural lesions, reflect insufficiency in neurovascular territories, and respond to immunity due to brain dysfunction. The book unveils current and upcoming methods in stroke biomarker research, translational innovative approaches to diagnosis, and advances in medical technologies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Dambinova, S.A., Martinez, B., Peplow, P.V. (2020). Integrative Biomarkers in Stroke. In: Peplow, P.V., Martinez, B., Dambinova, S.A. (eds) Stroke Biomarkers. Neuromethods, vol 147. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9682-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9682-7_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9681-0
Online ISBN: 978-1-4939-9682-7
eBook Packages: Springer Protocols